- Home
- Â /Â Recipharm
Recipharm
Total Funding
$242.4 M
Revenue
KR705.5 M
FY, 2023
Recipharm Summary
Company Summary
- Overview
- Recipharm is a pharmaceutical contract development and manufacturing company. It offers solids, semi-solids, and liquids manufacturing, technology transfer, pharmaceutical packaging, and other solutions. The company also provides analytical and regulatory services.
- Type
- Private
- Status
- Active
- Founded
- 1995
- HQ
- Stockholm, SE | view all locations
- Website
- https://www.recipharm.com/
- Cybersecurity rating
- ESG rating
Table of Contents
Key People
Joaquim Mascaro, Chief Financial Officer
Gregor Kawaletz, Chief Commercial Officer
Vikas Gupta, President, ReciBioPharm
Operating MetricsView all
Business Areas
4
FY, 2023
Sites
25
16.7%
FY, 2023
Markets
100
FY, 2023
LocationsView all
20 locations detected
Stockholm, Stockholms län HQ
Sweden
Vasagatan 10
Boxborough, MA
United States
1414 Massachusetts Ave
Watertown, MA
United States
650 Pleasant St
Kaysersberg, Grand Est
France
23 Av. Georges Ferrenbach
Cuxhaven, NDS
Germany
Zeppelinstraße 2
Monheim am Rhein, NRW
Germany
Alfred-Nobel-Straße 10
Recipharm Financials
Summary Financials
- Revenue (FY, 2023)
- kr705.5M
- Net income (FY, 2023)
- (kr8.8B)
- Cash (FY, 2023)
- kr491.6M
- EBIT (FY, 2023)
- (kr337.9M)